Hence, investigating the presence of possible associations between PRSs and atrophy in specific areas associated with AD in APOE ε4 carriers, but especially in non-carriers, could provide insights into the effectiveness of these scores in predicting early atrophy in high-risk individuals and into the utility of PRS as a biological indicator and as a tool for early detection of the disease. This evidence concerns the gene APOE and Alzheimer disease.